((自动化翻译由路透提供，请见免责声明 )) (更新)
1月14日 - ** 大麻公司股价下跌，原因是美国 缉毒署(美国缉毒署) 法官周一取消了 (link) 的听证会，以审议 将大麻从第一类毒品调整为第三类毒品 的提议。
** 尽管大麻在美国几十个州都是合法的，但大麻被列入第一类，这使得大多数传统的美国银行都无法与大麻公司开展业务。
** Tilray Brands 下跌 1.4%，Cresco Labs 下跌 1.5
** 在加拿大上市的 Canopy Growth 下跌 3.2%，Trulieve Cannabis 下跌 2.2%，Curaleaf Holdings 下跌 2.9
** 缉毒局行政法官约翰-穆鲁尼（John Mulrooney）取消了原定于 1 月 21 日举行的择优听证会，并将听证会延期至少三个月。
** 晨星（Morningstar）分析师克里斯托弗-英顿（Kristoffer Inton）表示，虽然该行业的股票波动并不罕见，但最近的下跌是 自11月大选以来跌势的延续 ，"因为市场似乎越来越看跌重新安排上市的可能性"。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.